期刊文献+

番茄红素对人体安全性及抗氧化作用 被引量:6

Antioxidant effects of lycopene and its impact on human health
原文传递
导出
摘要 目的探讨番茄红素对人体的安全性和抗氧化作用。方法将120名健康志愿者按血清丙二醛(MDA)含量随机分为试食组和对照组,试食组连续服用番茄红素90 d,对照组服用安慰剂,测定2组人群血清中MDA含量及超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)活性和安全性指标。结果试食前后,试食组志愿者血清MDA含量分别为4.06和3.61 nmoL/mL,下降11.03%;SOD活性分别为90.7和96.7 U/mL,上升6.80%;GSH-Px活性分别为122.6和136.9 NU/mL,上升11.74%,与对照组比较,差异均有统计学意义(P<0.01);试食前后2组人群各项安全性指标均在正常范围内。结论番茄红素可提高人体抗氧化能力,且对人体健康无损害。 Objective To assess antioxidant effects of lycopene and its impact on human health.Methods A tatal of 120 healthy volunteers were divided into test group and control group randomly according to serum content of malondialdehyde(MDA).Subjects in test group were orally given lycopene consecutively for 90 days.Contents of MDA,activities of superoxide dismutase(SOD) and glutathione peroxidase(GSH-Px),and indexes of safety were determined at 90th day of the trial.Results In the test group,MDA content was 4.06 nmoL/mL before feeding and 3.61 nmoL/mL after feeding,with a decrease rate of 11.03%.The SOD activity was 90.7 U/mL before feeding and 96.7 U/mL after feeding,with an increase rate of 6.80%.The GSH-Px activity was 122.6 NU/mL before feeding and 136.9 NU/mL after feeding,with an increase rate of 11.74%.The indexes of test group were all significantly different from those of the control group(P0.01 for all).All safety indexes were in normal range.Conclusion Lycopene could enhance antioxidative function and has no toxic effect observed in human body.
出处 《中国公共卫生》 CAS CSCD 北大核心 2012年第11期1475-1476,共2页 Chinese Journal of Public Health
关键词 番茄红素 安全性 抗氧化 lycopene safety antioxidation
  • 相关文献

参考文献6

  • 1解瑞宁,沈新南.番茄红素生物学作用及与慢性病的关系[J].中国公共卫生,2005,21(1):112-113. 被引量:14
  • 2中华人民共和国卫生部.保健食品检验与评价技术规范[S].北京:卫生部卫生法制与监督司编印.2003:38-42.
  • 3Ried K,Fakler P. Protective effect of lycopene on serum choles- terol and blood pressure : meta-analyses of intervention trials [J]. Maturitas,2011,68(4) :299 -310.
  • 4Jian WC, Chiou MH, Chen YT. Twenty-eight-day oral toxicity study of lycopene from recombinant Escherichia coli in rats[ J]. Regul Toxicol Pharmaco1,2008,52 ( 2 ) : 163 - 168.
  • 5Jonker D, Kuper CF, Fraile N. Ninety-day oral toxicity study of lycopene from Blakeslea trispora in rats[J]. Regul Toxicol Phar- maco1,2003,37 ( 3 ) : 396 - 406.
  • 6Christian MS, Schulte S, Hellwig J. Developmental ( embryo-fetal toxicity/teratogenicity) toxicity studies of synthetic crystalline ly- copene in rats and rabbits[ J]. Food Chem Toxico1,2003,41 (6) : 773 -783.

二级参考文献20

  • 1Sasaki S, Tsubono Y, Okubo S, et al. Effects of three - month oral supplementation of beta- cartoene and vitamin C on serum concentrations of carotenoids and vitamins in middle- aged subjects:a pilot study for a randomized controlled trial to prevent gastric cancer in high - risk Japanese population[ J ]. Jpn J Cancer Res, 2000, 91 (5):464 - 470.
  • 2Klipstein- Grobusch K, Launer LJ. Serum carotenoids and atherosclerosis. The Rotterdam Study [ J ]. Atherosclerosis, 2000, 148 ( 1 ): 49 -56.
  • 3Tang AM, Smit E, Swmba RD, et al. Improved antioxidant status among HIV - infected injectary drug users on potent antiretroviral therapy[J] .J Acquir Immue Defic Syndr, 2000, 23(4) :321 - 326.
  • 4Yloen K, Alfthan G, Groop L, et al. Dietary intakes and plasma concentrations ofcarotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study[J]. Am J Clin Nutr, 2003, 77(6): 1434 - 1441.
  • 5Van KH, Brouwer IA, West CE, et al. Bioavailability of lutein from vegetables is 15 times higher than that of beta- carotene[J]. Am J Clim Nutr, 1999, 70(2): 179 - 182.
  • 6Eichler O, SiesH, Stahl W. Divergent optimum levels of lycopene,beta - carotene and lutein protecting against UVB irradiation in human fibroblastst[J]. Photochen Photobio, 2002, 75(5) :503 - 506.
  • 7Vibeke B, ST Lauridsen, Bahran D, et al. Dose - response effercts of lycopene on selected drug- metabolizing and antioxidant enzymes in the rat[J ]. Cancer Letters, 2000,154:201 - 210.
  • 8Amir H, Karas M, Giat J, et al. Lycopene and 1, 25 - dihydroxyvitamin in D3 cooperate in the inhibition of cell cycle progress and induction in HL - 60 leukemic cell[J ]. Nutr Cancer, 1999, 31( 1 ): 105-115.
  • 9Karas M, Amir H, Fishman D, et al. Lycopene interferes with cell cycle progression and insulin - like growth factor I signal in mammary cancer cells[J]. Nutr Cancer, 1999, 31(1): 105 - 112.
  • 10Stahl W, yon Laar J, Martin HD, et al. Stimulation of gap junctional communication: comparison of acyclo - retinoic acid and lycopene [J ]. Arch Biochem Biophys, 2000, 373(1): 271 - 274.

共引文献50

同被引文献101

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部